Predict your next investment

Non-Profit Foundation
braintumor.org

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

About National Brain Tumor Society

National Brain Tumor Society (NBTS) is dedicated to help: empower individuals with information, online programs, caring support, and direct connections to others going through the same challenges; fund transformative research to lead more rapidly to new therapies for adult and pediatric brain tumors, and ultimately to cures; advocate for brain tumor patients, families, caregivers, healthcare professionals, and researchers.

National Brain Tumor Society Headquarter Location

124 Watertown Street Suite 2D

Watertown, Massachusetts, 02472,

United States

617-924-9997

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing National Brain Tumor Society

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find National Brain Tumor Society in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest National Brain Tumor Society News

EndBrainCancer Initiative To Join National Brain Tumor Society, American Brain Tumor Society, And The Ivy Center At Barrow Neurological Institute To "Shine A Light" On The Deadliest Type Of Brain Cancer

Jun 21, 2021

EndBrainCancer Initiative To Join National Brain Tumor Society, American Brain Tumor Society, And The Ivy Center At Barrow Neurological Institute To "Shine A Light" On The Deadliest Type Of Brain Cancer Patient Advocacy Organization to Join Forces with Others in a Day that Will Virtually Gather Leading Researchers, Members of Congress, Survivors, Patients, Caregivers, and the Brain Tumor Community Author: Jun 21, 2021 3:15 PM EDT SEATTLE, June 21, 2021 /PRNewswire/ -- The EndBrainCancer Initiative (EBCI) today announced that it will be joining forces again with the National Brain Tumor Society  (NBTS), the American Brain Tumor Association  (ABTA), The Ivy Center at Barrow Neurological Institute , and others on July 21, 2021 to raise public awareness of glioblastoma (GBM) and honor those individuals who have lost their lives and survivors of this deadly form of brain cancer. Initially introduced to the Senate by a bipartisan group of U.S. senators, the inaugural GBM Awareness Day took place on July 17, 2019 in person at our U.S. capital. This year's event, spearheaded by the National Brain Tumor Society, will virtually gather leading researchers, members of congress, patients, caregivers, and their families and friends for a day of educational programming, community discussions, and engagement. We are encouraging all members of the brain tumor community to come together in a Virtual Town Hall on July 21. More information HERE . According to the EndBrainCancer Initiative, GBM Awareness Day represents an opportunity to raise national consciousness about everyone's stake in finding a cure for this disease. EBCI has several activities planned for the next several weeks to raise public awareness of this important event as well as boost participation:  A digital and social media campaign to create widespread awareness of National Glioblastoma Day and the importance of finding a cure for this devastating disease. A key objective of this campaign is to increase engagement and foster a sense of community within EBCI's constituents and supporters and learn what action steps they can take to help create change for GBM patients and families. Audience generation activities to encourage people to sign up and raise their voice in the National Brain Tumor Society (NBTS) live Virtual Town Hall. Solicitation of patient stories and the creation of mini "National GBM Day Patient Videos" to highlight the unique journeys of those affected by the disease and the harsh reality that brain cancer can impact anyone, even healthy adults and what National GBM Day means to them personally as survivors. EBCI President & Chair, Dellann Elliott Mydland has this to say about National GBM Day: "The EndBrainCancer Initiative and I are honored and excited to participate in this very important national awareness initiative. In our ongoing work with patients and their families, we are reminded every single day about the challenges they face and their courage in fighting this devastating disease as well as the toll that this disease takes on their lives and those of their loved ones. It is our fervent HOPE that this national effort results in increased funding for research, increased knowledge about GBM and other forms of cancer, and ultimately more treatment options for this disease." Disease education, awareness, and outreach support provided by Karyopharm Pharmaceuticals , Novocure , Genentech , and other supporters. About the EndBrainCancer Initiative The EndBrainCancer Initiative  (EBCI, formerly the Chris Elliott Fund) is a national brain tumor patient advocacy and services organization and 501(c) 3 social enterprise with offices and its "Direct Connect" Center & Referral Clinic located in Redmond, Washington. Now celebrating 19 years of service, EBCI remains committed to extending survival and bringing HOPE to the lives of patients and their families. Since its inception, EBCI has assisted thousands of patients, caregivers, and their families in their brain tumor journey and is acknowledged as a premier resource for the brain cancer community globally. 2021 marks an exciting new chapter for EBCI as it builds on past successes to pivot to a sustainable business model that supports greatly expanded programs, services and continued global leadership. You can support EBCI's efforts, programs and services through providing a gift, designating funds, a sponsorship or grant; contact us today at wecare@endbraincancer.org  or www.endbraincancer.org . Media Contact: Dellann Elliott Mydland 425.785.8489 | Dellann@EndBrainCancer.org View original content to download multimedia: http://www.prnewswire.com/news-releases/endbraincancer-initiative-to-join-national-brain-tumor-society-american-brain-tumor-society-and-the-ivy-center-at-barrow-neurological-institute-to-shine-a-light-on-the-deadliest-type-of-brain-cancer-301316664.html SOURCE End Brain Cancer Initiative (EBCI) By

National Brain Tumor Society Investments

2 Investments

National Brain Tumor Society has made 2 investments. Their latest investment was in Global Coalition for Adaptive Research as part of their Grant on January 1, 2019.

CBI Logo

National Brain Tumor Society Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/16/2019

Grant

Global Coalition for Adaptive Research

$0.75M

Yes

1

8/5/2010

Grant - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/16/2019

8/5/2010

Round

Grant

Grant - II

Company

Global Coalition for Adaptive Research

Subscribe to see more

Amount

$0.75M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

National Brain Tumor Society Portfolio Exits

1 Portfolio Exit

National Brain Tumor Society has 1 portfolio exit. Their latest portfolio exit was Forte Biosciences on April 13, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2017

IPO

$991

1

Date

4/13/2017

Exit

IPO

Companies

Valuation

$991

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.